Galope, Arlyn .

HRN: 23-35-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2023
CEFUROXIME 1.5GM (VIAL)
07/22/2023
07/24/2023
IV
1.5grams
Now Then Q8
Prophylaxis For OR; Bacterial Vaginosis
Waiting Final Action 
07/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/22/2023
07/24/2023
IV
500mg
Now Then Q8
Prophylaxis For OR; Bacterial Vaginosis
Waiting Final Action 
07/23/2023
CEFOTAXIME 500MG (VIAL)
07/23/2023
07/29/2023
ORAL
500mg
BID
Sp LTCS
Waiting Final Action 
07/23/2023
METRONIDAZOLE 500MG (TAB)
07/23/2023
07/29/2023
ORAL
500mg
Tid
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: